Eric Druyts

2.7k total citations
80 papers, 1.9k citations indexed

About

Eric Druyts is a scholar working on Epidemiology, Infectious Diseases and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eric Druyts has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 13 papers in Infectious Diseases and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eric Druyts's work include HIV/AIDS Research and Interventions (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Diabetes Treatment and Management (7 papers). Eric Druyts is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Diabetes Treatment and Management (7 papers). Eric Druyts collaborates with scholars based in Canada, United States and Switzerland. Eric Druyts's co-authors include Edward J. Mills, Kristian Thorlund, Steve Kanters, Chakrapani Balijepalli, Ping Wu, Robert S. Hogg, Chakrapani Balijepalli, Viviane D. Lima, Julio Montaner and Kamal Desai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Eric Druyts

76 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Druyts Canada 26 524 406 250 227 216 80 1.9k
Deborah Shatin United States 27 321 0.6× 270 0.7× 133 0.5× 168 0.7× 103 0.5× 44 2.3k
Alexis Ogdie United States 42 474 0.9× 210 0.5× 295 1.2× 188 0.8× 129 0.6× 291 7.6k
Étienne Audureau France 32 597 1.1× 403 1.0× 80 0.3× 173 0.8× 177 0.8× 197 3.5k
Fatma M. Shebl United States 29 712 1.4× 342 0.8× 53 0.2× 317 1.4× 464 2.1× 101 2.5k
Julie Marsh Australia 20 568 1.1× 160 0.4× 98 0.4× 81 0.4× 106 0.5× 120 3.1k
Scott P. Kelly United States 26 414 0.8× 195 0.5× 48 0.2× 261 1.1× 245 1.1× 56 3.2k
John Hornberger United States 21 281 0.5× 115 0.3× 153 0.6× 221 1.0× 85 0.4× 42 2.8k
Sada Nand Dwivedi India 27 306 0.6× 95 0.2× 114 0.5× 152 0.7× 122 0.6× 125 2.5k
Chen‐Yi Wu Taiwan 24 269 0.5× 159 0.4× 68 0.3× 188 0.8× 105 0.5× 96 1.9k
Mary Codd Ireland 30 372 0.7× 213 0.5× 72 0.3× 173 0.8× 61 0.3× 97 3.5k

Countries citing papers authored by Eric Druyts

Since Specialization
Citations

This map shows the geographic impact of Eric Druyts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Druyts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Druyts more than expected).

Fields of papers citing papers by Eric Druyts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Druyts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Druyts. The network helps show where Eric Druyts may publish in the future.

Co-authorship network of co-authors of Eric Druyts

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Druyts. A scholar is included among the top collaborators of Eric Druyts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Druyts. Eric Druyts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balijepalli, Chakrapani, et al.. (2024). Humanistic burden of mucopolysaccharidoses: a systematic literature review. Current Medical Research and Opinion. 40(4). 709–722. 3 indexed citations
2.
Balijepalli, Chakrapani, et al.. (2024). EPH101 Prevalence of Sickle Cell Disease in the Middle East: A Systematic Literature Review. Value in Health. 27(12). S240–S241. 1 indexed citations
3.
Balijepalli, Chakrapani, et al.. (2021). The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks. Frontiers in Digital Health. 3. 667016–667016. 23 indexed citations
4.
Balijepalli, Chakrapani, et al.. (2021). Quality of Life in Wilson’s Disease: A Systematic Literature Review. Journal of health economics and outcomes research. 8(2). 105–113. 5 indexed citations
5.
Desai, Kamal, et al.. (2020). Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Desai, Kamal, et al.. (2020). On Pandemic Preparedness: How Well is the Modeling Community Prepared for COVID-19?. PharmacoEconomics. 38(11). 1149–1151. 3 indexed citations
7.
8.
Thorlund, Kristian, Ping Wu, Eric Druyts, et al.. (2016). Comparative tolerability of treatments for acute migraine: A network meta-analysis. Cephalalgia. 37(10). 965–978. 47 indexed citations
9.
10.
Thorlund, Kristian, Eric Druyts, Wu Ping, et al.. (2015). Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐Analysis. Journal of the American Geriatrics Society. 63(5). 1002–1009. 49 indexed citations
11.
12.
13.
Kanters, Steve, Eric Druyts, Edward J. Mills, & Kristian Thorlund. (2014). What drives the comparative effectiveness of biologics vs methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors. Lara D. Veeken. 53(7). 1264–1273. 6 indexed citations
14.
15.
Thorlund, Kristian, Zafar Zafarí, Eric Druyts, Edward J. Mills, & Mohsen Sadatsafavi. (2014). The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD. Cost Effectiveness and Resource Allocation. 12(1). 8–8. 11 indexed citations
16.
Thorlund, Kristian, et al.. (2014). Cost-effectiveness of golimumab versus infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis. Value in Health. 17(3). A38–A38. 2 indexed citations
17.
Funk, Anna, et al.. (2012). Cohort Profile: The MUg Observational Cohort. International Journal of Epidemiology. 41(6). 1594–1594f. 10 indexed citations
18.
Lima, Viviane D., P. Richard Harrigan, Martin Sénécal, et al.. (2010). Epidemiology of Antiretroviral Multiclass Resistance. American Journal of Epidemiology. 172(4). 460–468. 15 indexed citations
19.
Joy, Ruth, Eric Druyts, Viviane D. Lima, et al.. (2008). Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(4). 500–505. 97 indexed citations
20.
Zala, Carlos, Keith Chan, Marcelo A. Beltrán, et al.. (2008). Determinants of Treatment Access in a Population‐based Cohort of HIV‐positive Men and Women Living in Argentina. Journal of the International AIDS Society. 10(1). 78–78. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah Shatin Breakdown of academic impact, for papers by Alexis Ogdie Breakdown of academic impact, for papers by Étienne Audureau Breakdown of academic impact, for papers by Fatma M. Shebl Breakdown of academic impact, for papers by Julie Marsh Breakdown of academic impact, for papers by Scott P. Kelly Breakdown of academic impact, for papers by John Hornberger Breakdown of academic impact, for papers by Sada Nand Dwivedi Breakdown of academic impact, for papers by Chen‐Yi Wu Breakdown of academic impact, for papers by Mary Codd
Rankless by CCL
2026